# FDA recall D-0513-2023

> **Preferred Pharmaceuticals, Inc.** · Class II · drug recall initiated 2023-03-23.

## Product

Clopidogrel Tablets USP, 75 mg, 90-count bottles, Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703, NDC 68788-8190-9

## Reason for recall

cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0513-2023
- **Recalling firm:** Preferred Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-03-23
- **Report date:** 2023-04-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Anaheim, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0513-2023

## Citation

> AI Analytics. FDA recall D-0513-2023. Retrieved 2026-06-23 from https://api.ai-analytics.org/recall/D-0513-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*